Concurrent Chemoradiotherapy Remains Standard of Care in Locally Advanced SCCHN

A phase 3 noninferiority study has found that in patients with nonoperable locally advanced squamous cell cancer of the head and neck, concurrent chemoradiotherapy remains the standard treatment, according to results presented at the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting.
Oncology Nurse Advisor